In Vitro Diagnostics Tests and Technologies

NIH Rapid Acceleration of Diagnostics (RADxSM) Tech Initiative

Tuesday, September 28, 2021

11:15 AM – 12:15 PM ET

Location: Virtual

Virtual Moderator(s)

Steven C. Schachter, MD

RADx Chief, Chief Academic Officer
Consortia for Improving Medicine with Innovation & Technology (CIMIT)

Virtual Speaker(s)

Ingo Chakravarty

VP/GM Rapid Diagnostics Solutions
Thermo Fisher Scientific
Nancy Gagliano, MD, MBA

Implementation Lead
RADx Tech
Tim Stenzel, MD, PhD

Director, OHT7: Office of In Vitro Diagnostics and Radiological Health, Office of Product Evaluation and Quality
CDRH, FDA
Bruce Tromberg, PhD

Director
National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH)

The NIH Rapid Acceleration of Diagnostics (RADs) Tech Initiative was launched to speed innovation in the development and deployment of technologies for COVID-19 diagnostic testing. This multi-phase technology accelerator program is based on an "innovation funnel" design and has successfully developed and deployed new laboratory-based and point-of-care (POC) tests to help contain the COVID-19 global pandemic. This novel support structure, which has involved close collaboration among government, industry, non-profit, and academic partners, has succeeded in accelerating the typical years-long technology development and commercialization timeline to under 12 months. The NIH and its partner organizations aim to share best practices and lessons learned from this unique experience and model.